SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from MARIMED INC. (MRMD) (CIK 0001522767) (MRMD) — Apr 27, 2021

MARIMED INC. (MRMD) (CIK 0001522767)
Date: April 27, 2021 · CIK: 0001522767 · Accession: 0001493152-21-009819

AI Filing Summary & Sentiment

File numbers found in text: 333-255338

Date
April 27, 2021
Author
Chief
Form
CORRESP
Company
MARIMED INC. (MRMD) (CIK 0001522767)

Letter

United States Securities and Exchange Commission Division of Corporation Finance Office of Technology Attn: Mr. Mitchell Austin, Staff Attorney Re: MariMed Inc. (the “Company”) Registration Statement on Form S-3, SEC File No. 333-255338 (the “Registration Statement”)

Dear Mr. Austin:

In connection with the proposed public offering of Company securities under the above referenced Registration Statement, the Company hereby requests, pursuant to Rule 461(a) under the Rules and Regulations promulgated under the Securities Act of 1933, as amended, that the Registration Statement become effective at 4.00 p.m. Eastern Daylight Savings Time, on Wednesday, April 28, 2021, or as soon thereafter as practicable.

With respect to this request the Company acknowledges that:

● Should the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

● The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

● The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very
truly yours,
MARIMED
INC.

Show Raw Text
CORRESP
1
filename1.htm

MARIMED
INC.

10
Oceana Way

Norwood,
Massachusetts 02062

April
27, 2021

FILED
VIA EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

Office
of Technology

Washington,
DC 20549

Attn:
Mr. Mitchell Austin, Staff Attorney

    Re:
    MariMed
    Inc. (the “Company”)

    Registration
    Statement on Form S-3, SEC File No. 333-255338

    (the
    “Registration Statement”)

Dear
Mr. Austin:

In
connection with the proposed public offering of Company securities under the above referenced Registration Statement, the Company hereby
requests, pursuant to Rule 461(a) under the Rules and Regulations promulgated under the Securities Act of 1933, as amended, that the
Registration Statement become effective at 4.00 p.m. Eastern Daylight Savings Time, on Wednesday, April 28, 2021, or as soon thereafter
as practicable.

With
respect to this request the Company acknowledges that:

    ●
    Should
    the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose
    the Commission from taking any action with respect to the Registration Statement;

    ●
    The
    action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective
    does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement;
    and

    ●
    The
    Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission
    or any person under the federal securities laws of the United States.

    Very
    truly yours,

    MARIMED
    INC.

    By:
    /s/
    Jon R. Levine

    Jon
    R. Levine

    Chief
    Financial Officer